FDA approves new larger production setup for Genmab drug

After the US health authorities approved a new production setup at Horizon Therapeutics, which holds the rights to Genmab's drug Tepezza, the company expects that current supply-related issues will soon be resolved.

Photo: PR / Genmab

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list, which handles online sales.

Further reading

Related articles

Latest news

See all jobs